Digitalization And Secular Trends Will Expand Biotech Cold Chain Services
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 9 Analysts
Published
09 Aug 25
Updated
16 Aug 25
AnalystHighTarget's Fair Value
US$16.00
45.1% undervalued intrinsic discount16 Aug
US$8.79
1Y
-6.4%7D
8.7%